Recent national studies reveal a troubling trend: as more parents decline the routine vitamin K injection for newborns, incidents of vitamin K deficiency bleeding (VKDB) in infants have risen sharply. The findings underscore the importance of this simple, proven preventive measure for the health of our youngest citizens.
Key findings from the research
A study published in the Journal of the American Medical Association examined medical records for over 11 million babies born between 2017 and 2025. During that period, the proportion of infants receiving the vitamin K shot fell from 97.7 % to 95 %.
Correspondingly, cases of VKDB increased by 347.1 %, climbing from 24 per 100,000 infants to 107 per 100,000. A related analysis of 5.2 million infants reported similar results, confirming that the rise in bleeding events is not limited to documented VKDB cases alone.
Among the infants who developed VKDB, 80 % had not received the vitamin K injection. Moreover, roughly 7 % of those diagnosed with VKDB also suffered a brain bleed, and 2.4 % of all VKDB cases involved intracranial bleeding.
Expert commentary
Dr. Elizabeth R. Wolf, a pediatrician at Virginia Commonwealth University and lead author of the first study, said the magnitude of the increase was unexpected. “We knew refusals were climbing, but the scale of the rise in bleeding cases was striking,” she told Well Informed.
Dr. Kristan Scott, a neonatologist at Children’s Healthcare of Atlanta and co‑author of the second study, emphasized the difficulty of capturing every VKDB case. “Diagnosing vitamin K deficiency bleeding requires clinicians to recognize and document the link to vitamin K,” she explained. “Our broader approach aimed to avoid missing events that might not be recorded as VKDB specifically.”
Dr. Jaspreet Loyal of Yale University added, “This research makes clear that serious bleeding in the absence of vitamin K prophylaxis is real, dangerous, and preventable.”
Why vitamin K matters for newborns
Vitamin K is essential for blood clotting. Newborns are born with very low stores, and the vitamin does not cross the placenta efficiently nor is it supplied in sufficient amounts through breast milk. While formula provides a modest amount, it is not enough to protect against VKDB.
Without adequate vitamin K, infants are at risk for internal bleeding that can be fatal or cause permanent disability. The American Academy of Pediatrics has recommended an intramuscular vitamin K injection within the first six hours of life for babies weighing at least 3.3 pounds since the 1960s. The shot is widely regarded as safe and highly effective.
Implications for parents and providers
The data suggest that declining the vitamin K injection puts infants at a significantly higher risk of bleeding, including potentially life‑threatening brain hemorrhages. Health professionals are urged to continue counseling parents on the proven benefits of the vaccine‑like prophylaxis.
For families who value informed decision‑making, the research provides clear evidence that the vitamin K shot is a critical safeguard during the first months of life, until a child begins solid foods and can obtain sufficient vitamin K from diet.
Looking ahead
Both studies call for heightened awareness among pediatricians, obstetricians, and new parents. As the nation grapples with a range of health challenges, ensuring that newborns receive this simple, cost‑effective protection aligns with the broader goal of preserving family health and protecting the most vulnerable members of our communities.
Original reporting: WPBF (Treasure Coast / Hearst) — read the source article.